House Staffers Concerned With State 'Right To Try' Laws, 10 More Expected

House Energy and Commerce Committee staffers are concerned that "Right to Try" laws enacted by five states and under consideration by others will dilute the pool of people entering clinical trials, and say the committee's 21st Century Cures initiative may offer alternative ways to quicken patient access to new therapies without sidestepping the FDA approval process. But the Goldwater Institute, the driving force behind the Right To Try laws, flatly rejects those concerns and expects at least 10 more state...

Subscriber Login

If you are a InsideHealthPolicy.com subscriber, or you have an active trial subscription, please login here:

Enter your InsideHealthPolicy.com username.
Enter the password that accompanies your username.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.